Goodwill and Intangible Assets (Tables)
|
3 Months Ended |
Mar. 31, 2021 |
| Goodwill and Intangible Assets Disclosure [Abstract] |
|
| Summary of changes in the carrying amount of goodwill |
The following table summarizes the changes in the carrying amount of goodwill: | | | | | | | (in millions) | | | Balance as of December 31, 2020 | $ | 33,124 | | | | Measurement period adjustments(a) | (564) | | | Foreign currency translation adjustments | (211) | | | Balance as of March 31, 2021 | $ | 32,349 | |
(a) Measurement period adjustments relate to the acquisition of Allergan (see Note 4).
|
| Summary of definite-lived intangible assets |
The following table summarizes intangible assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2021 | | December 31, 2020 | | (in millions) | Gross carrying amount | | Accumulated amortization | | Net carrying amount | | Gross carrying amount | | Accumulated amortization | | Net carrying amount | | Definite-lived intangible assets | | | | | | | | | | | | | Developed product rights | $ | 87,602 | | | $ | (13,395) | | | $ | 74,207 | | | $ | 87,707 | | | $ | (11,620) | | | $ | 76,087 | | | License agreements | 8,488 | | | (3,129) | | | 5,359 | | | 7,828 | | | (2,916) | | | 4,912 | | | Total definite-lived intangible assets | 96,090 | | | (16,524) | | | 79,566 | | | 95,535 | | | (14,536) | | | 80,999 | | | Indefinite-lived research and development | 1,727 | | | — | | | 1,727 | | | 1,877 | | | — | | | 1,877 | | | Total intangible assets, net | $ | 97,817 | | | $ | (16,524) | | | $ | 81,293 | | | $ | 97,412 | | | $ | (14,536) | | | $ | 82,876 | |
|
| Summary of indefinite-lived intangible assets |
The following table summarizes intangible assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2021 | | December 31, 2020 | | (in millions) | Gross carrying amount | | Accumulated amortization | | Net carrying amount | | Gross carrying amount | | Accumulated amortization | | Net carrying amount | | Definite-lived intangible assets | | | | | | | | | | | | | Developed product rights | $ | 87,602 | | | $ | (13,395) | | | $ | 74,207 | | | $ | 87,707 | | | $ | (11,620) | | | $ | 76,087 | | | License agreements | 8,488 | | | (3,129) | | | 5,359 | | | 7,828 | | | (2,916) | | | 4,912 | | | Total definite-lived intangible assets | 96,090 | | | (16,524) | | | 79,566 | | | 95,535 | | | (14,536) | | | 80,999 | | | Indefinite-lived research and development | 1,727 | | | — | | | 1,727 | | | 1,877 | | | — | | | 1,877 | | | Total intangible assets, net | $ | 97,817 | | | $ | (16,524) | | | $ | 81,293 | | | $ | 97,412 | | | $ | (14,536) | | | $ | 82,876 | |
|